PharmAla Biotech supplies MDMA to Harvard med school for clinical trial | Where to order Skittles Moonrock online
Learn where to buy cannabis online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
👉 Click here to Visit our shop! 🛒
The Harvard contract comes at a time when the prestigious university is renewing its focus on psychedelics research.
PharmAla Biotech Holdings Inc., (CSE: MDMA), (OTC: MDXXF), will supply MDMA to a clinical study at Harvard Medical School’s McLean Hospital. The company announced this. Wednesday.
McLean Hospital in Belmont, Massachusetts is the largest psychiatric facility affiliated with Harvard Medical School. The financial terms of the agreement have not been disclosed.
PharmAla is a drug that can be purchased online. specializes In MDMA Research and Manufacturing, claims to be the only supplier of clinically-grade MDMA outside of clinical trials.
The company has introduced an Online tool Researchers can access MDMA products from the company and adapt their clinical trials protocols to its specifications.
PharmAla has also announced that it will attend the CPHI Pharmaceutical Conference in Milan where Shane Morris the company’s Chief Operating Officer hinted at the management meeting with potential European distributors.
Morris stated that “PharmAla has had discussions with a number potential distribution partners on the European market over the past few months.”
The university has signed a contract with Harvard Renewing its focus Psychedelic research. Harvard announced in 2023 a $16-million program to study the effects of psychedelics on society and culture. You can also read more about it here. From its controversial psychedelic history in the 1960s.
PharmAla emphasized its focus on maintaining strong relations with regulators. It described itself as a “regulatory-first” organization.
Leave a Reply
Want to join the discussion?Feel free to contribute!